|
The slides to be stained
for melanosoma specific antigen (MSA) comprised:
1: malignant melanoma
(small intestine), 2: granulosa cell tumour (ovary),
3:
malignant melanoma (testis), 4: adrenal gland, 5: blue
nevus.
Criteria for assessing an MSA staining as optimal
included: a strong and
distinct intracytoplasmic reaction in the tumour cells of
the malignant melanomas and the blue naevus (which expressed
scarce amounts of MSA compared to the melanomas), while no
staining reaction should be seen in other cells.
66
laboratories submitted stainings. At the assessment, 30
laboratories achieved optimal staining
(45%), 19 good (29%), 13 borderline
(20%), and 4
poor staining (6%).
All used mAb HMB45,
which
was obtained from DakoCytomation (53),
Enzo (6), Ventana (5), and Novocastra (2).
Mandatory for an optimal
staining was a protocol based on a proper dilution of the
primary Ab in combination with an efficient
HIER
and a non-biotin based detection system or an efficient
biotin blocking (if using a
biotin based detection system).
Among 9 using
a ready-to-use (RTU) primary antibody,
only one got an optimal result. Laboratories using Tris-EDTA/EGTA
and Citrate heating buffers got
almost
equal results. However,
among protocols without HIER only one of 8 gave an optimal
result.
The most frequent causes of insufficient
stainings (often in combination) were:
- A too low
concentration of the primary Ab.
- An RTU Ab.
- No or insufficient
HIER.
- Proteolytic
pre-treatment (often resulting in a weak demonstration of
MSA as well as a false positive staining of plasma cells).
- Use of a
biotin based detection system without suppression of
endogenous biotin.
|